QOF database

Home | News | Downloads
DR. WALLACE & PARTNERS

DR. WALLACE & PARTNERS

LODGE HEALTH, LODGE HEALTH, 20 LODGE MANOR, COLERAINE

HF 4

The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 21 25 84.0%
HF 4 2011 20 30 66.7%
HF 4 2012 22 32 68.8%
HF 4 2013 19 26 73.1%
HF004 2014 5 5 100.0%
HF004 2015 None None NA%
HF004 2016 None None NA%
HF004 2017 34 38 89.5%
HF004 2018 43 48 89.6%
HF004 2019 50 55 90.9%
HF004 2020 50 54 92.6%
HF004 2021 60 67 89.6%